Federated Hermes’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Federated Hermes's ANGO Position: Q1 2026 in Review
Federated Hermes sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 11,576 shares — an estimated $149K sold.
Federated Hermes first reported a position in ANGO in Q4 2014 and held it in 17 quarters. The position peaked at $1.92M in Q3 2020. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Federated Hermes reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
- Federated Hermes sold 11,576 AngioDynamics shares in Q1 2026, an estimated $149K.
- Federated Hermes first reported a position in AngioDynamics in Q4 2014 and held it in 17 quarters.
- Federated Hermes's AngioDynamics position peaked at $1.92M in Q3 2020.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.